Hong Kong-listed Wang On Group Limited (Wang On) confirmed that shareholders have formally endorsed the divestment of its Target Company. At the Special General Meeting (SGM) held on 11 September 2026, the sole ordinary resolution covering the Sale and Purchase Agreement and the related Guarantee Agreement received 6.86 billion shares voted in favour—representing 100% of the votes cast—with no votes against.

The SGM was convened further to a joint announcement by Wang On and Wai Yuen Tong Medicine Holdings Limited dated 16 July 2026 and the Company’s circular issued on 21 August 2026. Tricor Investor Services Limited acted as the scrutineer for the poll.

Wang On’s entire issued share capital on the SGM date stood at 13.54 billion shares, with no treasury shares outstanding. No shareholders were required to abstain, and there were no indications of opposition prior to the meeting.

The approval authorises any one director to take all necessary actions to implement and complete the disposal and associated guarantee arrangements. Executive Director Ms. Stephanie and Independent Non-Executive Director Mr. Chan Yung attended the meeting in person or via electronic means.